Emergent BioSolutions Statistics
Total Valuation
EBS has a market cap or net worth of $97.10 million. The enterprise value is $845.60 million.
| Market Cap | 97.10M |
| Enterprise Value | 845.60M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, after market close.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
EBS has 52.20 million shares outstanding. The number of shares has increased by 2.20% in one year.
| Shares Outstanding | 52.20M |
| Shares Change (YoY) | +2.20% |
| Shares Change (QoQ) | +0.58% |
| Owned by Insiders (%) | 1.88% |
| Owned by Institutions (%) | 79.22% |
| Float | 51.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.09 |
| Forward PS | 0.09 |
| PB Ratio | 0.15 |
| P/FCF Ratio | n/a |
| PEG Ratio | 1.55 |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.81 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.04, with a Debt / Equity ratio of 1.32.
| Current Ratio | 1.04 |
| Quick Ratio | 0.46 |
| Debt / Equity | 1.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.32 |
Financial Efficiency
Return on equity (ROE) is -86.80% and return on invested capital (ROIC) is -48.12%.
| Return on Equity (ROE) | -86.80% |
| Return on Assets (ROA) | -34.40% |
| Return on Capital (ROIC) | -48.12% |
| Revenue Per Employee | $655,813 |
| Profits Per Employee | -$475,313 |
| Employee Count | 1,600 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 2.08 |
Taxes
In the past 12 months, EBS has paid $29.30 million in taxes.
| Income Tax | 29.30M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -83.00% in the last 52 weeks. The beta is 1.19, so EBS's price volatility has been higher than the market average.
| Beta (1Y) | 1.19 |
| 52-Week Price Change | -83.00% |
| 50-Day Moving Average | 2.38 |
| 200-Day Moving Average | 3.29 |
| Relative Strength Index (RSI) | 32.75 |
| Average Volume (30 Days) | 3,024,550 |
Short Selling Information
The latest short interest is 5.70 million, so 10.92% of the outstanding shares have been sold short.
| Short Interest | 5.70M |
| Short Previous Month | 6.20M |
| Short % of Shares Out | 10.92% |
| Short % of Float | 11.13% |
| Short Ratio (days to cover) | 2.64 |
Income Statement
In the last 12 months, EBS had revenue of $1.05 billion and -$760.50 million in losses. Loss per share was -$14.85.
| Revenue | 1.05B |
| Gross Profit | 343.90M |
| Operating Income | -726.40M |
| Pretax Income | -731.20M |
| Net Income | -760.50M |
| EBITDA | -518.20M |
| EBIT | -643.30M |
| Loss Per Share | -$14.85 |
Balance Sheet
The company has $111.70 million in cash and $860.20 million in debt, giving a net cash position of -$748.50 million or -$14.34 per share.
| Cash & Cash Equivalents | 111.70M |
| Total Debt | 860.20M |
| Net Cash | -748.50M |
| Net Cash Per Share | -$14.34 |
| Equity / Book Value | 649.30M |
| Book Value Per Share | 12.44 |
| Working Capital | 28.20M |
Cash Flow
In the last 12 months, operating cash flow was -$206.30 million and capital expenditures -$51.60 million, giving a free cash flow of -$257.90 million.
| Operating Cash Flow | -206.30M |
| Capital Expenditures | -51.60M |
| Free Cash Flow | -257.90M |
| FCF Per Share | -$5.04 |
Margins
Gross margin is 32.77%, with operating and profit margins of -69.23% and -72.48%.
| Gross Margin | 32.77% |
| Operating Margin | -69.23% |
| Pretax Margin | -69.68% |
| Profit Margin | -72.48% |
| EBITDA Margin | -49.39% |
| EBIT Margin | -61.31% |
| FCF Margin | -24.58% |
Dividends & Yields
EBS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -2.20% |
| Shareholder Yield | -2.20% |
| Earnings Yield | -783.23% |
| FCF Yield | -265.61% |
Analyst Forecast
The average price target for EBS is $5.00, which is 168.82% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.00 |
| Price Target Difference | 168.82% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | -5.53% |
| EPS Growth Forecast (5Y) | -69.31% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
EBS has an Altman Z-Score of -0.54 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.54 |
| Piotroski F-Score | 4 |